These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 20507861

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Population pharmacokinetic analysis of colistin methanesulfonate and colistin after intravenous administration in critically ill patients with infections caused by gram-negative bacteria.
    Plachouras D, Karvanen M, Friberg LE, Papadomichelakis E, Antoniadou A, Tsangaris I, Karaiskos I, Poulakou G, Kontopidou F, Armaganidis A, Cars O, Giamarellou H.
    Antimicrob Agents Chemother; 2009 Aug; 53(8):3430-6. PubMed ID: 19433570
    [Abstract] [Full Text] [Related]

  • 23. New colistin population pharmacokinetic data in critically ill patients suggesting an alternative loading dose rationale.
    Grégoire N, Mimoz O, Mégarbane B, Comets E, Chatelier D, Lasocki S, Gauzit R, Balayn D, Gobin P, Marchand S, Couet W.
    Antimicrob Agents Chemother; 2014 Dec; 58(12):7324-30. PubMed ID: 25267662
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Determination of colistin in human plasma, urine and other biological samples using LC-MS/MS.
    Ma Z, Wang J, Gerber JP, Milne RW.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Feb 01; 862(1-2):205-12. PubMed ID: 18187372
    [Abstract] [Full Text] [Related]

  • 27. Greater optimisation of pharmacokinetic/pharmacodynamic parameters through a loading dose of intravenous colistin in paediatric patients.
    Wacharachaisurapol N, Phasomsap C, Sukkummee W, Phaisal W, Chanakul A, Wittayalertpanya S, Chariyavilaskul P, Puthanakit T.
    Int J Antimicrob Agents; 2020 Jun 01; 55(6):105940. PubMed ID: 32179149
    [Abstract] [Full Text] [Related]

  • 28. Evaluating the stability of colistin and colistin methanesulphonate in human plasma under different conditions of storage.
    Dudhani RV, Nation RL, Li J.
    J Antimicrob Chemother; 2010 Jul 01; 65(7):1412-5. PubMed ID: 20413406
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Pharmacokinetics of colistin methanesulfonate (CMS) in healthy Chinese subjects after single and multiple intravenous doses.
    Zhao M, Wu XJ, Fan YX, Zhang YY, Guo BN, Yu JC, Cao GY, Chen YC, Wu JF, Shi YG, Li J, Zhang J.
    Int J Antimicrob Agents; 2018 May 01; 51(5):714-720. PubMed ID: 29305956
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Multiple-dose pharmacokinetics of intravenous telavancin in healthy male and female subjects.
    Wong SL, Barriere SL, Kitt MM, Goldberg MR.
    J Antimicrob Chemother; 2008 Oct 01; 62(4):780-3. PubMed ID: 18586659
    [Abstract] [Full Text] [Related]

  • 33. Safety and pharmacokinetic evaluation of intravenous colistin methanesulfonate sodium in Japanese healthy male subjects.
    Mizuyachi K, Hara K, Wakamatsu A, Nohda S, Hirama T.
    Curr Med Res Opin; 2011 Dec 01; 27(12):2261-70. PubMed ID: 21995648
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Removal of colistin during intermittent haemodialysis in two critically ill patients.
    Marchand S, Frat JP, Petitpas F, Lemaître F, Gobin P, Robert R, Mimoz O, Couet W.
    J Antimicrob Chemother; 2010 Aug 01; 65(8):1836-7. PubMed ID: 20501487
    [No Abstract] [Full Text] [Related]

  • 36. Comparison of once-, twice- and thrice-daily dosing of colistin on antibacterial effect and emergence of resistance: studies with Pseudomonas aeruginosa in an in vitro pharmacodynamic model.
    Bergen PJ, Li J, Nation RL, Turnidge JD, Coulthard K, Milne RW.
    J Antimicrob Chemother; 2008 Mar 01; 61(3):636-42. PubMed ID: 18227094
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.